• In the pharmaceutical industry: prevention of various oxidative stress diseases, for the production of dietary supplements and medicines.
• In the food industry: as an antioxidant and preservative.
• In sports nutrition: as a food additive.
• In the cosmetics industry: as an antioxidant.
• In the plant industry: as a food additive.
• In animal husbandry: as a food additive.

Taxifolin Siberian - P has a tonic effect, increases physical performance, promotes the regulation of metabolic processes in the body;

Protects endothelial cells of the microcirculatory channel with activation of peripheral blood circulation;

Improves the functional state of the cardiovascular system;

Normalises lipid metabolism, providing prevention of atherosclerosis;

Increases blood flow in cerebral vessels with protection of brain neurons from inflammation and toxic damage;

Reduces the risk of developing diabetes mellitus by reducing hyperglycaemia and normalising body weight;

It has anti-inflammatory, antibacterial and antiviral properties by activating cellular and humoral immunity; Prevents allergic reactions by inhibiting the production of histamine;

• Dihydroquercetin 98.0%
• Arabinogalactan - 1.0%
• Neosil - 1.0%;

Dihydroquercetin leads to a decrease in blood sugar levels, with normalisation of indicators of fat metabolism, has a positive effect on the feeling of satiety. Activate the metabolism of carbohydrates, preventing the conversion of the latter into fat. Eliminating increased capillary permeability, strengthens the vascular wall, reduces its swelling and inflammation. Has an antiaggregant effect, which contributes to the improvement of microcirculation. Slows the development of diabetic polyneuropathy and retinopathy. Exhibits antibacterial and anti-inflammatory properties; can inhibit Helicobacter pylori, without affecting the beneficial microorganisms of the intestinal biota. Prevents diseases of the gastrointestinal tract, stimulates the regeneration of gastric mucosa, promotes healing of gastric ulcers and duodenal ulcers. Having antioxidant properties, is effective after hepatitis, cholecystitis, pancreatitis, colitis, promoting rapid recovery of the digestive tract.

Where Dihydroquercetin is used:

Cardiology: vascular atherosclerosis, coronary heart disease, hypertension, chronic heart failure;

Neurology: astheno-vegetative syndrome of various etiologies, during the recovery period after diseases, operations and traumas; radiculopathy;

Otorhinolaryngology:

Acute and chronic rhinosinusitis, adenoiditis, tonsillitis, pharyngitis, otitis media;

Gastroenterology: chronic gastritis, gastric and duodenal ulcer, chronic hepatitis, cholecystitis, pancreatitis, colitis;

Nephrology: acute and chronic pyelonephritis, cystitis;

Dermatology:

Dermatitis, trophic ulcers, acne;

Endocrinology: diabetes mellitus type 1 and 2, metabolic syndrome, chronic adrenal insufficiency;

Urology: prostate adenoma, chronic prostatitis;

Gynaecology: acute and chronic vulvitis, colpitis, cervicitis, mastopathy, menopause;

Pulmonology:

Acute and chronic bronchitis, acute respiratory viral infections, chronic obstructive pulmonary disease, tuberculosis;

Ophthalmology: conjunctivitis, cataract, retinopathy;

Immunology: chronic fatigue syndrome, allergic conditions;

For prevention and rehabilitation after COVID-19-induced disease;

Accompaniment during chemotherapy and radiotherapy as symptomatic agents

Pharmacological properties:



Has antioxidant activity, inhibits the processes of lipid peroxidation of cell membranes and serum lipoproteins, prevents the damaging effect of free radicals, reactivates sulfhydryl compounds and vitamin C, glutathione, tocopherols, prevents the transition of adrenaline to toxic adrenochrome.

Exhibits antitoxic effect, protecting the liver from hepatotropic poisons, including tetracycline, tetrachloromethane, ethyl alcohol, neutralises nitrosamines carcinogenic for the gastrointestinal tract.

Capillaroprotective action is expressed in the inhibition of hyaluronidase, an enzyme that violates the integrity of the vascular wall, improves intrathecal respiration, myocardial contractility, reduces the zone of infection of the heart muscle, contributes to the normalisation of excitability and conduction.

It has the ability to bind to benzodiazepine receptors in the brain, causing sedative, hypotensive and analgesic effects, affecting benzodiazepine receptors of platelets and reducing the production of thromboxanes, reduces the thrombogenic potential of blood plates.